Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.49 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.49 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.49 |
| ▸ | CALCR | P30988 | 4/20 | 0.48 |
| ▸ | NPY2R | P49146 | 7/20 | 0.47 |
| ▸ | NPY4R | P50391 | 7/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.47 |
| ▸ | NPY1R | P25929 | 5/20 | 0.47 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.46 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.46 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.46 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29403602 | 0.88 | OPRD1 (0.55) | CALCRHCRTR1HCRTR2NTSR1NTSR2 | |
| SCHEMBL30402076 | 0.86 | NTSR1 (0.47) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30401751 | 0.85 | NPY2R (0.47) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30277901 | 0.85 | NPY2R (0.55) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30751612 | 0.85 | CALCR (0.54) | MAPK8MAPK9MAPK10CALCRNPY2R | |
| SCHEMBL30242254 | 0.84 | NPY2R (0.46) | NPY2RNPY4RNPY5RNPY1RNTSR1 | |
| SCHEMBL30311356 | 0.84 | NPY2R (0.49) | NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30311239 | 0.83 | NPY2R (0.47) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30974381 | 0.83 | RAMP3 (0.51) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30512495 | 0.83 | NTSR1 (0.55) | NTSR1NTSR2SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 779 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4268412-B1 | METHOD FOR ENCRYPTING PLAIN TEXT | MERCEDES BENZ GROUP AG (DE) | 2025-12-03 | — | — | EP | claimed |
| WO-2024210594-A1 | METHOD AND APPARATUS FOR TRANSMITTING AND RECEIVING UPLINK CHANNEL IN WIRELESS COMMUNICATION SYSTEM | 엘지전자 주식회사 | 2024-10-10 | — | — | WO | claimed |
| WO-2024210490-A1 | METHOD AND DEVICE FOR TRANSMITTING AND RECEIVING RANDOM ACCESS RESPONSE | 엘지전자 주식회사 | 2024-10-10 | — | — | WO | claimed |
| CN-118104182-A | Method for encrypting plaintext | 梅赛德斯-奔驰集团股份公司 | 2024-05-28 | — | — | CN | claimed |
| WO-2024080649-A1 | METHOD AND DEVICE FOR TRANSMITTING/RECEIVING PPDU ON BASIS OF TRIGGER FRAME IN WIRELESS LAN SYSTEM | 엘지전자 주식회사 | 2024-04-18 | — | — | WO | claimed |
| CN-112911642-B | CPRI data compression method for wireless communication base station | 上海守正通信技术有限公司 | 2024-01-19 | — | — | CN | claimed |
| CN-109680000-B | Method for establishing HCV cell model by using tree shrew marrow mesenchymal stem cells | 中国医学科学院医学生物学研究所 | 2022-07-19 | — | — | CN | claimed |
| WO-2022103017-A1 | METHOD AND SYSTEM FOR PROVIDING CACHED DATA | 주식회사 픽스트리 | 2022-05-19 | — | — | WO | claimed |
| CN-114410683-A | RIM3-RNAi based on Cre-lox recombination system and application thereof | 中国人民解放军空军军医大学 | 2022-04-29 | — | — | CN | claimed |
| CN-114369623-A | Cre-lox recombination system-based Synaptotagmin2-RNAi and application thereof | 中国人民解放军空军军医大学 | 2022-04-19 | — | — | CN | claimed |
| EP-3842981-B1 | DYNAMIC RANDOMIZATION OF PASSWORD CHALLENGE | ST MICROELECTRONICS INT NV (CH) | 2022-04-06 | — | — | EP | claimed |
| CN-112111493-B | Mouse model for resisting MLL leukemia constructed by changing expression level of Hoxb13, model construction method and application | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | 2022-02-11 | — | — | CN | claimed |
| US-20260144801-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-05-28 | — | — | US | disclosed |
| WO-2026106240-A1 | DEVICE AND METHOD FOR SUPPORTING QUICK MEDIA SWITCHING | 엘지전자 주식회사 | 2026-05-21 | — | — | WO | disclosed |
| US-20260137813-A1 | GENOME EDITING METHODS AND CONSTRUCTS | FOND TELETHON ETS (IT) | 2026-05-21 | — | — | US | disclosed |
| CN-116999565-B | Multiple small nucleic acid delivery system and multiple target vaccine | 四川大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-113994949-A | Rat-proof bird-repelling device | 广东电网有限责任公司 | 2022-02-01 | — | — | CN | disclosed |
| US-20220023257-A1 | TREATMENT OF DEMENTIA-ASSOCIATED TAUOPATHIES | DEUTSCHES ZENTRUM FÜR NEURODEGENERATIVE ERKRANKUNGEN E.V. (DZNE) (DE) | 2022-01-27 | — | — | US | disclosed |
| EP-3672136-B1 | METHOD AND APPARATUS FOR GENERATING AND RECEIVING PILOT SIGNAL | HUAWEI TECH CO LTD (CN) | 2022-01-26 | — | — | EP | disclosed |
| US-11232076-B2 | System and methods for bandwidth-efficient cryptographic data transfer | AtomBeam Technologies, Inc (US) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137813-A1 | GENOME EDITING METHODS AND CONSTRUCTS | DCLRE1B, AARS1, CPSF6 | MAPK8 3862/4885MAPK9 4160/4885MAPK10 4606/4885 |
| US-20220023257-A1 | TREATMENT OF DEMENTIA-ASSOCIATED TAUOPATHIES | HTR7, MAPT, HTR1A | MAPK8 3826/4885MAPK9 4559/4885MAPK10 3782/4885 |
| US-20260144801-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | CPT1B, HPGD, PTGES | MAPK8 3544/4885MAPK9 4157/4885MAPK10 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.